Fibrobiologics Inc (FBLG)

$0.72 -0.03 (-3.43%)
Market Cap 27.58M
Revenue (ttm) 0.00
Net Income (ttm) -11.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 238,529
Avg Vol 254,590
Day's Range N/A - N/A
Shares Out 38.26M
Stochastic %K 20%
Beta -0.79
Analysts Strong Sell
Price Target $11.00

Company Profile

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

Industry: Biotechnology
Sector: Healthcare
Phone: 281-651-5150
Address:
455 East Medical Center Boulevard, Suite 300, Houston, United States
LadyDDeath
LadyDDeath Jun. 23 at 2:46 PM
$FBLG
0 · Reply
BULLTRADER0007
BULLTRADER0007 Jun. 20 at 5:12 PM
$FBLG 0 borrow 🚀🚀🚀🚀🚀
1 · Reply
BWTE
BWTE Jun. 18 at 12:34 PM
$FBLG when $16
0 · Reply
JarvisFlow
JarvisFlow Jun. 17 at 12:30 PM
D. Boral Capital has adjusted their stance on FibroBiologics ( $FBLG ), setting the rating to Buy with a target price of 16.
0 · Reply
BioTuesdays
BioTuesdays Jun. 9 at 3:16 PM
FibroBiologics announced the appointment of Jason D. Davis, CPA, as chief financial officer (CFO), effective immediately $FBLG https://biotuesdays.com/2025/06/09/fibrobiologics-names-jason-d-davis-as-cfo/
0 · Reply
FilingTracker
FilingTracker Jun. 6 at 7:14 PM
$FBLG 5.579% position revealed: https://www.sec.gov/Archives/edgar/data/1958777/000164117225014002/xslSCHEDULE_13G_X01/primary_doc.xml
0 · Reply
Cookem_up09
Cookem_up09 May. 28 at 5:57 PM
$FBLG waiting patiently unlike most. Makes no sense why people are selling at all time lows lol
1 · Reply
FilingTracker
FilingTracker May. 27 at 9:59 PM
$FBLG CSO increases position by 177.8%: https://www.sec.gov/Archives/edgar/data/1958777/000164117225012539/xslF345X05/ownership.xml
0 · Reply
ZacksSCR
ZacksSCR May. 22 at 5:07 PM
$FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis… https://buff.ly/4PThcBo
0 · Reply
MisoHawny
MisoHawny May. 15 at 8:35 PM
$FBLG wasn’t that their previous price target?
0 · Reply
Latest News on FBLG
FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

Jun 16, 2025, 4:35 PM EDT - 8 days ago

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

FibroBiologics to Present at the BIO International Convention 2025

Jun 16, 2025, 9:50 AM EDT - 9 days ago

FibroBiologics to Present at the BIO International Convention 2025

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

Jun 9, 2025, 8:30 AM EDT - 16 days ago

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

May 16, 2025, 8:30 AM EDT - 5 weeks ago

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 14, 2025, 4:30 PM EDT - 5 weeks ago

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

FibroBiologics Presenting at the ThymUS 2025 Meeting

Apr 29, 2025, 9:15 AM EDT - 2 months ago

FibroBiologics Presenting at the ThymUS 2025 Meeting

FibroBiologics Presents at the ThymUS 2025 Meeting

Apr 29, 2025, 9:15 AM EDT - 2 months ago

FibroBiologics Presents at the ThymUS 2025 Meeting

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

Apr 11, 2025, 8:30 AM EDT - 2 months ago

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

Apr 8, 2025, 8:30 AM EDT - 2 months ago

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

Apr 2, 2025, 8:30 AM EDT - 3 months ago

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 31, 2025, 4:25 PM EDT - 3 months ago

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces 2025 Annual Meeting of Stockholders

Mar 27, 2025, 8:30 AM EDT - 3 months ago

FibroBiologics Announces 2025 Annual Meeting of Stockholders

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

Mar 21, 2025, 8:30 AM EDT - 3 months ago

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

Mar 4, 2025, 8:30 AM EST - 4 months ago

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

Feb 27, 2025, 8:30 AM EST - 4 months ago

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

Feb 5, 2025, 9:15 AM EST - 5 months ago

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

Dec 30, 2024, 4:30 PM EST - 6 months ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

Dec 30, 2024, 2:12 PM EST - 6 months ago

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

FibroBiologics Announces $25 Million Financing

Dec 23, 2024, 7:55 AM EST - 6 months ago

FibroBiologics Announces $25 Million Financing

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

Nov 19, 2024, 9:15 AM EST - 7 months ago

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

Nov 14, 2024, 9:15 AM EST - 7 months ago

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12, 2024, 4:20 PM EST - 8 months ago

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

Oct 29, 2024, 9:15 AM EDT - 8 months ago

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

Oct 28, 2024, 9:31 AM EDT - 8 months ago

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

Oct 18, 2024, 8:30 AM EDT - 8 months ago

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

Oct 16, 2024, 9:15 AM EDT - 9 months ago

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

Oct 11, 2024, 9:31 AM EDT - 9 months ago

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

Sep 30, 2024, 9:31 AM EDT - 9 months ago

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

FibroBiologics Engages Southern Star Research as CRO in Australia

Sep 19, 2024, 9:31 AM EDT - 9 months ago

FibroBiologics Engages Southern Star Research as CRO in Australia

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

Sep 12, 2024, 9:31 AM EDT - 10 months ago

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 9:31 AM EDT - 10 months ago

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

Aug 20, 2024, 9:31 AM EDT - 11 months ago

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

FibroBiologics Files 2024 Second Quarter Report

Aug 7, 2024, 6:52 PM EDT - 11 months ago

FibroBiologics Files 2024 Second Quarter Report

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

Jul 15, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

Jun 25, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

FibroBiologics Set to Join Russell 2000® Index

Jun 13, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Set to Join Russell 2000® Index

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

Jun 6, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

FibroBiologics Announces 2024 Annual Meeting of Stockholders

May 15, 2024, 4:30 PM EDT - 1 year ago

FibroBiologics Announces 2024 Annual Meeting of Stockholders

FibroBiologics Files 2024 First Quarter Report

May 14, 2024, 5:24 PM EDT - 1 year ago

FibroBiologics Files 2024 First Quarter Report

FibroBiologics to Present at the BIO International Convention 2024

May 7, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at the BIO International Convention 2024

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

Apr 11, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

Apr 4, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

Mar 28, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

Mar 19, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

FibroBiologics to Present at Advanced Wound Care Summit USA

Mar 13, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at Advanced Wound Care Summit USA

FibroBiologics Appoints Ruben A. Garcia as General Counsel

Mar 6, 2024, 9:31 AM EST - 1 year ago

FibroBiologics Appoints Ruben A. Garcia as General Counsel

FibroBiologics Files 2023 Form 10-K Annual Report

Feb 29, 2024, 5:44 PM EST - 1 year ago

FibroBiologics Files 2023 Form 10-K Annual Report

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum

Feb 20, 2024, 9:31 AM EST - 1 year ago

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum

FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases

Feb 13, 2024, 9:31 AM EST - 1 year ago

FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases

FibroBiologics Announces Three United States Patents for Fibroblast Technology

Feb 8, 2024, 9:31 AM EST - 1 year ago

FibroBiologics Announces Three United States Patents for Fibroblast Technology

LadyDDeath
LadyDDeath Jun. 23 at 2:46 PM
$FBLG
0 · Reply
BULLTRADER0007
BULLTRADER0007 Jun. 20 at 5:12 PM
$FBLG 0 borrow 🚀🚀🚀🚀🚀
1 · Reply
BWTE
BWTE Jun. 18 at 12:34 PM
$FBLG when $16
0 · Reply
JarvisFlow
JarvisFlow Jun. 17 at 12:30 PM
D. Boral Capital has adjusted their stance on FibroBiologics ( $FBLG ), setting the rating to Buy with a target price of 16.
0 · Reply
BioTuesdays
BioTuesdays Jun. 9 at 3:16 PM
FibroBiologics announced the appointment of Jason D. Davis, CPA, as chief financial officer (CFO), effective immediately $FBLG https://biotuesdays.com/2025/06/09/fibrobiologics-names-jason-d-davis-as-cfo/
0 · Reply
FilingTracker
FilingTracker Jun. 6 at 7:14 PM
$FBLG 5.579% position revealed: https://www.sec.gov/Archives/edgar/data/1958777/000164117225014002/xslSCHEDULE_13G_X01/primary_doc.xml
0 · Reply
Cookem_up09
Cookem_up09 May. 28 at 5:57 PM
$FBLG waiting patiently unlike most. Makes no sense why people are selling at all time lows lol
1 · Reply
FilingTracker
FilingTracker May. 27 at 9:59 PM
$FBLG CSO increases position by 177.8%: https://www.sec.gov/Archives/edgar/data/1958777/000164117225012539/xslF345X05/ownership.xml
0 · Reply
ZacksSCR
ZacksSCR May. 22 at 5:07 PM
$FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis… https://buff.ly/4PThcBo
0 · Reply
MisoHawny
MisoHawny May. 15 at 8:35 PM
$FBLG wasn’t that their previous price target?
0 · Reply
Cookem_up09
Cookem_up09 May. 15 at 6:25 PM
$FBLG
0 · Reply
JarvisFlow
JarvisFlow May. 15 at 5:33 PM
D. Boral Capital has adjusted their stance on FibroBiologics ( $FBLG ), setting the rating to Buy with a target price of 16.
0 · Reply
jkr007
jkr007 May. 14 at 5:10 PM
$FBLG If this company has no revenues do not expect the price to increase, in my opinion.
1 · Reply
LabPsycho
LabPsycho May. 10 at 2:08 PM
$FBLG @resistancebreakers @Cookem_up09 I do not know why - have you tried different charting websites?. But I do know that I posted my concerns about this company and their 'technology' shortly after their IPO when it was $45/sh. IMO it was a Hard pass back then for several reasons / potential red flags I posted
1 · Reply
resistancebreakers
resistancebreakers May. 9 at 7:54 PM
$FBLG super cheap IPO play 🔥
0 · Reply
builderup
builderup May. 8 at 8:50 PM
$FBLG $BDSX Oversold! Oversold! Oversold! I’m averaging down on BDSX and back in FBLG! Let’s go
1 · Reply
PenkeTrading
PenkeTrading May. 6 at 8:54 AM
I found you a Three Black Crows Candle Pattern on the daily chart of FibroBiologics, Inc. Common Stock. $FBLG #ThreeBlackCrows #NASDAQ
0 · Reply
Cookem_up09
Cookem_up09 Apr. 29 at 2:55 PM
$FBLG swingers dream right now. Need a steady run and hold though.
0 · Reply
ILIKETOSWING
ILIKETOSWING Apr. 28 at 2:56 PM
$ONDS 3/3 for the year, $SES, $FBLG, $LITM... Moving to $ONDS Looking to see over a dollar!
1 · Reply
ILIKETOSWING
ILIKETOSWING Apr. 28 at 12:24 PM
$LITM I personally like the way it looks, $FBLG & $SES worked out real well hope to see this go too
0 · Reply
Enoch120
Enoch120 Apr. 23 at 1:42 PM
$FBLG it’s good to see some attention on this company. The institutions are hanging in for great results.
0 · Reply
Cookem_up09
Cookem_up09 Apr. 22 at 2:20 PM
$FBLG what’d I say? Hover an around 1.50. No break away
0 · Reply